Alamar Biosciences, Inc. (California) (ALMR)
29.31
-1.23
(-4.03%)
USD |
NASDAQ |
Sep 01, 16:00
29.36
+0.05
(+0.17%)
After-Hours: 19:29
Alamar Biosciences Cash from Operations (TTM) : -56.62M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -56.62M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| 10X Genomics, Inc. | 127.08M |
| Personalis, Inc. | -92.30M |
| Twist Bioscience Corp. | -53.07M |
| Adaptive Biotechnologies Corp. | -21.01M |
| Champions Oncology, Inc. | -4.472M |